Sotyktu
Drug timelines are a Plus or Pro feature.
28 regulatory and trial events tracked for Sotyktu, covering 2017-04-17 to 2026-06-03. Get the full timeline:
Most recent: EMA Authorised: Sotyktu (deucravacitinib) — Bristol-Myers Squibb Pharma EEIG